• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Windlas Biotech Limited — Board Meeting, 05-02-2026: Outcome of Board Meeting

    05-02-2026 | 05:45 pm

    Windlas Biotech's board approved Q3 FY26 consolidated results: Revenue at Rs 233.10 Cr, PAT at Rs 15.00 Cr. For nine months, Revenue hit Rs 665.59 Cr, PAT Rs 50.47 Cr. The board also approved dissolving its US subsidiary, Windlas Inc.

    No comments yet. Be the first to comment!

    All announcements from Windlas Biotech Limited